Federal award
GENENTECH USA, INC
SPE2DP19F5674
Contract
Obligated and Ceiling
- Obligated (net)
- $4,343,441.64
- Ceiling (potential value, not spending)
- $4,343,441.64
- Current value
- $4,343,441.64
- Gross positive obligations
- $4,343,441.64
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- GENENTECH USA, INC · SA85BMHCTXK5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2DP
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- SPE2DP19F5674
- Parent vehicle (IDV PIID)
- SPE2DP18D0011
- Award type code
- C
- Actions
- 2 · Sep 6, 2019 to Nov 4, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 4, 2020 | FY2021 | P00001 | M | $0.00 | — |
| Sep 6, 2019 | FY2019 | 0 | — | $4,343,441.64 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.